Antibodies and PMBC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides.

The study investigates the effectiveness of two synthetic proteins, gp45 and p26, found in Equine infectious anemia virus (EIAV) in inducing immune responses in horses and mice. It found that both proteins were recognized by the immune system and could provoke an immune response, indicating their potential use in vaccine design.

Understanding EIAV and its Proteins

• The study focuses on Equine infectious anemia virus (EIAV), a lentivirus that causes a persistent infection in horses marked by recurring fevers and high levels of viremia (viruses circulating in the blood) associated with a new antigenic strain of the virus.
• The virus is made up of six proteins, with the study specifically focusing on two of them; an envelope glycoprotein gp45, and an internal protein p26.

Identification of Potential Immune Stimulators

• The researchers sought to identify the conserved epitopes (part of an antigen that is recognized by the immune system) in the two proteins that could stimulate both the humoral (antibody-mediated) and cellular (cell-mediated) immune responses.
• This is based on the observation that most infected horses can restrict EIAV replication to low levels and that the proteins gp45 and p26 carry highly conserved epitopes among lentiviruses.

Results of the Study

• Antibodies from all evaluated carrier horses recognized both gp45 and p26 peptides.
• Peripheral blood mononuclear cells (PBMC) from 80% of carrier horses responded to at least one peptide.
• BALB/c mice immunized with each of the peptides developed a humoral and cellular response. The antibodies were present 48 days and 63 days post immunization with gp45 or p26, respectively, with a higher positivity rate for gp45.
• The lymphoproliferation (increase in the number of lymphocytes, normal constituents of blood and important in the immune system) was higher in immunized mice than the control group, suggesting that the peptides helped stimulate this increase.

Implications for Vaccine Design

• These results suggest that both peptides gp45 and p26 could be included in effective vaccine design to induce long-term immunological memory, which would provide immunity against the virus.
• Further research is needed to understand the implications of these findings to vaccine design and to test the real-world effectiveness of such a vaccine.